Aclidinium

Aclidinium Brand Name– TUDORZA PRESSAIR

What is Aclidinium

Aclidinium bromide is an inhaled long-acting muscarinic antagonist (LAMA).

It is given twice daily for the long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

Statistically significant improvements in bronchodilation were demonstrated in all 3 placebo-controlled safety and efficacy trials.

According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines, aclidinium may be used as initial monotherapy in all groups of COPD patients; however, combination therapy with a long-acting beta-agonist (LABA) or inhaled corticosteroid (ICS) may be needed in patients in Group D or in patients still experiencing dyspnea or exacerbations upon follow-up.

Aclidinium bromide is not indicated for acute bronchospasm and is not indicated for the treatment of asthma.

Aclidinium bromide was approved by the FDA in 2012

Indications

  • chronic bronchitis
  • chronic obstructive pulmonary disease (COPD)
  • emphysema

For the maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema

Side Effects

  1. anaphylactoid reactions
  2. angioedema
  3. AV block
  4. blurred vision
  5. bronchospasm
  6. cardiac arrest
  7. corneal edema
  8. cough
  9. dental pain
  10. diabetes mellitus
  11. diarrhea
  12. dysuria
  13. headache
  14. heart failure
  15. ocular hypertension
  16. ocular pain
  17. pharyngitis
  18. prostatic hypertrophy
  19. rash
  20. rhinitis
  21. sinusitis
  22. urethral pain
  23. urinary retention
  24. urticaria
  25. visual impairment
  26. vomiting
  27. xerostomia

Monitoring Parameters

  • pulmonary function tests (PFTs)

Contraindications

  • acute bronchospasm
  • angioedema
  • anticholinergic medications
  • bladder obstruction
  • breast-feeding
  • children
  • closed-angle glaucoma
  • contact lenses
  • geriatric
  • infants
  • milk protein hypersensitivity
  • neonates
  • ocular exposure
  • ophthalmic administration
  • pregnancy
  • prostatic hypertrophy

Interactions

  • Albuterol; Ipratropium
  • Anticholinergics
  • Atropine
  • Atropine; Benzoic Acid; Hyoscyamine; Methenamine; Methylene Blue; Phenyl Salicylate
  • Atropine; Difenoxin
  • Atropine; Diphenoxylate
  • Atropine; Edrophonium
  • Atropine; Hyoscyamine; Phenobarbital; Scopolamine
  • Belladonna Alkaloids; Ergotamine; Phenobarbital
  • Belladonna; Opium
  • Benzoic Acid; Hyoscyamine; Methenamine; Methylene Blue; Phenyl Salicylate
  • Benztropine
  • Chlordiazepoxide; Clidinium
  • Dicyclomine
  • Flavoxate
  • Fluticasone; Umeclidinium; Vilanterol
  • Glycopyrrolate
  • Glycopyrrolate; Formoterol
  • Homatropine; Hydrocodone
  • Hyoscyamine
  • Hyoscyamine; Methenamine; Methylene Blue; Phenyl Salicylate; Sodium Biphosphate
  • Indacaterol; Glycopyrrolate
  • Ipratropium
  • Mepenzolate
  • Methacholine
  • Methenamine; Sodium Acid Phosphate; Methylene Blue; Hyoscyamine
  • Methscopolamine
  • Oxybutynin
  • Propantheline
  • Scopolamine
  • Tiotropium
  • Tiotropium; Olodaterol
  • Trihexyphenidyl
  • Umeclidinium
  • Umeclidinium; Vilanterol
15585

Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

15856